17 November 2017 - EMA, PMDA and FDA to further align data requirements and explore options to streamline paediatric development. ...
20 October 2017 - Actions address specific challenges identified by stakeholders. ...
1 August 2017 - EMA invites comments on reflection paper by 31 January 2018. ...
28 July 2017 - Public consultation to end on 31 October 2017. ...
25 July 2017 - Guidance outlines strategies to identify and mitigate risks for trial participants. ...
19 July 2017 - The EMA, eager to accelerate access to promising new drugs, may be getting too cosy with ...
6 July 2017 - Industry lobbying began shortly after British referendum last June. ...
3 July 2017 - Approach aims to facilitate development of medicines for rare paediatric diseases in general. ...
12 June 2017 - EMA, PMDA and FDA align data requirements and agree on areas of convergence. ...
6 June 2017 - The EMA, the United States FDA and Health Canada are co-organising a workshop to discuss the ...
7 March 2017 - EMA workshop will discuss role of patients, consumers and health care professionals. ...
27 February 2017 - Pharma groups look to evidence in normal medical settings to prove value for money. ...
9 February 2017 - Enpr-EMA workshop on 16 May 2017 opens for registration. ...
6 February 2017 - Follow-up activities addressing stakeholder needs. ...
2 February 2017 - The development of medicinal products has been shifting towards a value-driven model. ...